BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 36494778)

  • 1. Plasma and cerebrospinal fluid neurofilament light concentrations reflect neuronal damage in systemic lupus Erythematosus.
    Zervides KA; Janelidze S; Nystedt J; Gullstrand B; Nilsson P; Sundgren PC; Bengtsson AA; Hansson O; Jönsen A
    BMC Neurol; 2022 Dec; 22(1):467. PubMed ID: 36494778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum S100A8/A9 concentrations are associated with neuropsychiatric involvement in systemic lupus erythematosus: a cross-sectional study.
    Zervides KA; Jern A; Nystedt J; Gullstrand B; Nilsson PC; Sundgren PC; Bengtsson AA; Jönsen A
    BMC Rheumatol; 2022 Jul; 6(1):38. PubMed ID: 35804434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus.
    Lauvsnes MB; Zetterberg H; Blennow K; Kvaløy JT; Tjensvoll AB; Maroni S; Beyer MK; Greve OJ; Kvivik I; Alves G; Gøransson LG; Harboe E; Hirohata S; Omdal R
    J Neurol; 2022 Jun; 269(6):3064-3074. PubMed ID: 34800169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
    Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
    Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter lesions and brain atrophy in systemic lupus erythematosus patients: correlation to cognitive dysfunction in a cohort of systemic lupus erythematosus patients using different definition models for neuropsychiatric systemic lupus erythematosus.
    Cannerfelt B; Nystedt J; Jönsen A; Lätt J; van Westen D; Lilja A; Bengtsson A; Nilsson P; Mårtensson J; Sundgren PC
    Lupus; 2018 Jun; 27(7):1140-1149. PubMed ID: 29523054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between neurofilament, HMGB1, MMP9, ds DNA blood levels and cognitive impairment in patients with neuropsychiatric systemic lupus erythematosus.
    Ahmadzade A; Simani L; Roozbeh M; Farsad F; Sheibani M; Negaresh O; Emam MM; Rajaei A; Kazempour M; Ramezani M; Nazarpoor S
    Caspian J Intern Med; 2024; 15(1):58-65. PubMed ID: 38463908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal cerebral hemodynamics and blood-brain barrier permeability detected with perfusion MRI in systemic lupus erythematosus patients.
    Salomonsson T; Rumetshofer T; Jönsen A; Bengtsson AA; Zervides KA; Nilsson P; Knutsson M; Wirestam R; Lätt J; Knutsson L; Sundgren PC
    Neuroimage Clin; 2023; 38():103390. PubMed ID: 37003131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.
    Ho RC; Thiaghu C; Ong H; Lu Y; Ho CS; Tam WW; Zhang MW
    Autoimmun Rev; 2016 Feb; 15(2):124-38. PubMed ID: 26497108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
    Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished white matter integrity in patients with systemic lupus erythematosus.
    Schmidt-Wilcke T; Cagnoli P; Wang P; Schultz T; Lotz A; Mccune WJ; Sundgren PC
    Neuroimage Clin; 2014; 5():291-7. PubMed ID: 25161895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles.
    Jönsen A; Bengtsson AA; Nived O; Ryberg B; Truedsson L; Rönnblom L; Alm GV; Sturfelt G
    Lupus; 2003; 12(11):846-50. PubMed ID: 14667101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of central nervous system infections and experience in differential diagnosis from neuropsychiatric lupus erythematosus in a cohort of 8491 patients with systemic lupus erythematosus.
    Jiang M; Shi X; Gao X; Niu J; Hu X; Zhao L; Zhang X
    Arthritis Res Ther; 2019 Aug; 21(1):189. PubMed ID: 31426834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
    Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
    Lupus; 2015 Dec; 24(14):1492-7. PubMed ID: 26124236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score.
    Labouret M; Trebossen V; Ntorkou A; Bartoli S; Aubart M; Auvin S; Bader-Meunier B; Baudouin V; Corseri O; Dingulu G; Ducrocq C; Dumaine C; Elmaleh M; Fabien N; Faye A; Hau I; Hentgen V; Kwon T; Meinzer U; Ouldali N; Parmentier C; Pouletty M; Renaldo F; Savioz I; Benoist JF; Le Roux E; Ellul P; Melki I
    Lupus; 2024 Apr; 33(4):328-339. PubMed ID: 38315109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.
    Trysberg E; Nylen K; Rosengren LE; Tarkowski A
    Arthritis Rheum; 2003 Oct; 48(10):2881-7. PubMed ID: 14558094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
    Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
    Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
    PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus.
    Fang H; Lan L; Qu Y; Zhang Q; Lv J
    J Int Med Res; 2018 Jan; 46(1):485-491. PubMed ID: 28823196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile Neuropsychiatric Systemic Lupus Erythematosus: Identification of Novel Central Neuroinflammation Biomarkers.
    Labouret M; Costi S; Bondet V; Trebossen V; Le Roux E; Ntorkou A; Bartoli S; Auvin S; Bader-Meunier B; Baudouin V; Corseri O; Dingulu G; Ducrocq C; Dumaine C; Elmaleh M; Fabien N; Faye A; Hau I; Hentgen V; Kwon T; Meinzer U; Ouldali N; Parmentier C; Pouletty M; Renaldo F; Savioz I; Rozenberg F; Frémond ML; Lepelley A; Rice GI; Seabra L; Benoist JF; Duffy D; Crow YJ; Ellul P; Melki I
    J Clin Immunol; 2023 Apr; 43(3):615-624. PubMed ID: 36469191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.